Objective: Sports practice alters the homeostasis of athletes. To achieve homeostatic equilibrium, the integrated action of the neuroendocrine and immune systems is necessary. Here we studied the relation between cytokines, hormones and mood states in marathon runners. Methods: A total of 20 male recreational marathon runners (mean age = 35.7 ± 9 years) and 20 male sedentary individuals (mean age = 35.5 ± 7 years) were recruited. We compared the serum levels of growth hormone (GH), cortisol and interleukins 8 and 10 and the amounts of these two cytokines spontaneously produced by peripheral blood mononuclear cells. Blood samples of the sedentary group were collected at rest. Blood from the marathon runners was collected at rest (baseline: 24 h before the race), immediately after a marathon and 72 h after a marathon. Mood state analysis in both groups was performed using the 24-item Brunel Mood Scale (BRUMS). Results: Our results showed that, at rest, levels of interleukins 8 and 10 in the supernatant of culture cells, the serum concentration of GH, and tension and vigour (evaluated using the BRUMS), were significantly higher in athletes compared to sedentary people. Immediately after the race all serum parameters analysed were statistically higher than baseline values. At 72 h after the marathon, serum levels of hormones and interleukins returned to values at rest, but the concentrations of interleukins in the supernatant of culture cells showed a significant reduction compared to values at rest. Conclusion: The higher serum levels of GH in athletes at rest and the higher production of cytokines in culture without previous stimulus suggest that marathon runners present mechanisms that may be associated with preparing the body to perform prolonged strenuous exercise, such as a marathon.

Keywords:
Cytokines, Exercise, Stress hormone, Behaviour, Brunel Mood Scale
1.
Fragala MS, Kraemer WJ, Denegar CR, Maresh CM, Mastro AM, Volek JS: Neuroendocrine-immune interactions and responses to exercise. Sports Med 2011;41:621-639.
2.
Sandvik AM, Bartone PT, Hystad SW, Phillips TM, Thayer JF, Johnsen BH: Psychological hardiness predicts neuroimmunological responses to stress. Psychol Health Med 2013;18:705-713.
3.
Speisman RB, Kumar A, Rani A, Foster TC, Ormerod BK: Daily exercise improves memory, stimulates hippocampal neurogenesis and modulates immune and neuroimmune cytokines in aging rats. Brain Behav Immun 2013;28:25-43.
4.
Bilbo SD, Schwarz JM: The immune system and developmental programming of brain and behavior. Front Neuroendocrinol 2012;33:267-286.
5.
Aleman A, Torres-Aleman I: Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog Neurobiol 2009;89:256-265.
6.
Carro E, Trejo JL, Busiguina S, Torres-Aleman I: Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 2001;21:5678-5684.
7.
Kiess W, Butenandt O: Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization. J Clin Endocrinol Metab 1985;60:740-746.
8.
Zhang Y, Huang W, Li F, Feng S, Kang K, Xu J: Octreotide for the treatment of systemic lupus erythematosus: clinical effects and an in vitro study on its therapeutic mechanism. Lupus 2011;20:1172-1181.
9.
Nieman DC, Henson DA, Smith LL, Utter AC, Vinci DM, Davis JM, Kaminsky DE, Shute M: Cytokine changes after a marathon race. J Appl Physiol (1985) 2001;91:109-114.
10.
Vaisberg M, Suguri VM, Gregorio LC, Lopes JD, Bachi AL: Cytokine kinetics in nasal mucosa and sera: new insights in understanding upper-airway disease of marathon runners. Exerc Immunol Rev 2013;19:49-59.
11.
Suzuki K, Nakaji S, Yamada M, Liu Q, Kurakake S, Okamura N, Kumae T, Umeda T, Sugawara K: Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med Sci Sports Exerc 2003;35:348-355.
12.
Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993;11:165-190.
13.
Lang UE, Borgwardt S: Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 2013;31:761-777.
14.
Dantzer R: Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004;500:399-411.
15.
Voorhees JL, Tarr AJ, Wohleb ES, Godbout JP, Mo X, Sheridan JF, Eubank TD, Marsh CB: Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10. PLoS One 2013;8:e58488.
16.
Galambos SA, Terry PC, Moyle GM, Locke SA, Lane AM: Psychological predictors of injury among elite athletes. Br J Sports Med 2005;39:351-354.
17.
Fazackerley R, Lane AM, Mahoney C: Confirmatory factor analysis of the Brunel Mood Scale for use with water-skiing competition. Percept Mot Skills 2003;97:657-661.
18.
Terry PC, Lane AM, Lane HJ, Keohane L: Development and validation of a mood measure for adolescents. J Sports Sci 1999;17:861-872.
19.
Suzuki K, Yamada M, Kurakake S, Okamura N, Yamaya K, Liu Q, Kudoh S, Kowatari K, Nakaji S, Sugawara K: Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. Eur J Appl Physiol 2000;81:281-287.
20.
Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP: Exercise and the stress system. Hormones (Athens) 2005;4:73-89.
21.
Hejazi K, Hosseini SR: Influence of selected exercise on serum immunoglobulin, testosterone and cortisol in semi-endurance elite runners. Asian J Sports Med 2012;3:185-192.
22.
Eliakim A, Nemet D: Exercise training, physical fitness and the growth hormone-insulin-like growth factor-1 axis and cytokine balance. Med Sport Sci 2010;55:128-140.
23.
Steinacker JM, Lormes W, Kellmann M, Liu Y, Reissnecker S, Opitz-Gress A, Baller B, Gunther K, Petersen KG, Kallus KW, Lehmann M, Altenburg D: Training of junior rowers before world championships. Effects on performance, mood state and selected hormonal and metabolic responses. J Sports Med Phys Fitness 2000;40:327-335.
24.
Renaville R, Hammadi M, Portetelle D: Role of the somatotropic axis in the mammalian metabolism. Domest Anim Endocrinol 2002;23:351-360.
25.
Nagane M, Yoshimura K, Watanabe S, Nomura M: A possible connection between psychosomatic symptoms and daily rhythmicity in growth hormone secretion in healthy Japanese students. J Circadian Rhythms 2009;7:10.
26.
Miyabo S, Hisada T, Asato T, Mizushima N, Ueno K: Growth hormone and cortisol responses to psychological stress: comparison of normal and neurotic subjects. J Clin Endocrinol Metab 1976;42:1158-1162.
27.
Thompson PD, Venero CV: A history of medical reports on the Boston marathon: 112 years and still running. Med Sci Sports Exerc 2009;41:257-264.
28.
McCullough PA, Chinnaiyan KM, Gallagher MJ, Colar JM, Geddes T, Gold JM, Trivax JE: Changes in renal markers and acute kidney injury after marathon running. Nephrology (Carlton) 2011;16:194-199.
29.
Isgaard J, Aberg D, Nilsson M: Protective and regenerative effects of the GH/IGF-I axis on the brain. Minerva Endocrinol 2007;32:103-113.
30.
Aberg D: Role of the growth hormone/insulin-like growth factor 1 axis in neurogenesis. Endocr Dev 2010;17:63-76.
31.
Coculescu M: Blood-brain barrier for human growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab 1999;12:113-124.
32.
Mahesh VB, Dhandapani KM, Brann DW: Role of astrocytes in reproduction and neuroprotection. Mol Cell Endocrinol 2006;246:1-9.
33.
Aberg ND, Brywe KG, Isgaard J: Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 2006;6:53-80.
34.
Pedersen BK, Steensberg A, Schjerling P: Exercise and interleukin-6. Curr Opin Hematol 2001;8:137-141.
35.
Nielsen S, Pedersen BK: Skeletal muscle as an immunogenic organ. Curr Opin Pharmacol 2008;8:346-351.
36.
Nieman DC, Konrad M, Henson DA, Kennerly K, Shanely RA, Wallner-Liebmann SJ: Variance in the acute inflammatory response to prolonged cycling is linked to exercise intensity. J Interferon Cytokine Res 2011;32:12-17.
37.
Pedersen BK, Febbraio MA: Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008;88:1379-1406.
38.
Walsh NP, Gleeson M, Shephard RJ, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P: Position statement. Part one: immune function and exercise. Exerc Immunol Rev 2011;17:6-63.
39.
Mesquita AR, Correia-Neves M, Roque S, Castro AG, Vieira P, Pedrosa J, Palha JA, Sousa N: IL-10 modulates depressive-like behavior. J Psychiatr Res 2008;43:89-97.
40.
Peake JM, Suzuki K, Wilson G, Hordern M, Nosaka K, Mackinnon L, Coombes JS: Exercise-induced muscle damage, plasma cytokines, and markers of neutrophil activation. Med Sci Sports Exerc 2005;37:737-745.
41.
Marsland AL, Sathanoori R, Muldoon MF, Manuck SB: Stimulated production of interleukin-8 covaries with psychosocial risk factors for inflammatory disease among middle-aged community volunteers. Brain Behav Immun 2007;21:218-228.
42.
Xiong H, Boyle J, Winkelbauer M, Gorantla S, Zheng J, Ghorpade A, Persidsky Y, Carlson KA, Gendelman HE: Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J Neurosci Res 2003;71:600-607.
43.
Wang JL, Li SY, Luo YF, Zhai YP, Wei XQ: Changes of Th1/Th2 cytokines in immunocompetent patients with pulmonary cryptococcosis. Genet Mol Res 2013;12:5733-5742.
44.
Bernecker C, Scherr J, Schinner S, Braun S, Scherbaum WA, Halle M: Evidence for an exercise induced increase of TNF-α and IL-6 in marathon runners. Scand J Med Sci Sports 2013;23:207-214.
45.
Pervaiz N, Hoffman-Goetz L: Immune cell inflammatory cytokine responses differ between central and systemic compartments in response to acute exercise in mice. Exerc Immunol Rev 2012;18:142-157.
46.
Chakraborty S, Kaushik DK, Gupta M, Basu A: Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res 2010;88:1615-1631.
47.
Ransohoff RM, Brown MA: Innate immunity in the central nervous system. J Clin Invest 2012;122:1164-1171.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.